Method of inhibiting osteoclast activity

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) A61K 38/17 (2006.01) C07K 14/705 (2006.01) C12N 15/62 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2328140

Isolated soluble RANK receptors, DNAs encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated can be used to regulate osteoclastogenesis, and hence treat disease in which there is excess bone loss.

L'invention concerne des récepteurs RANK solubles isolés, des ADN codant ces récepteurs et des compositions pharmaceutiques préparées sur cette base. Les récepteurs isolés peuvent être utilisés pour réguler l'ostéoclastogenèse et, partant, pour traiter les maladies liées à une perte excessive de masse osseuse.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method of inhibiting osteoclast activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of inhibiting osteoclast activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting osteoclast activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1810906

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.